Centre Publications
2016
Please click here for publications from the current year
Please click here for publications from other years
| Author(s) | Title | Year | Citation |
|---|---|---|---|
| Beale DJ, Jones OA, Karpe AV, Dayalan S, Oh DY, Kouremenos KA, Ahmed W and Palombo EA | A review of analytical techniques and their application in disease diagnosis in breathomics and salivaomics research | 2016 | Int J Mol Sci 18(1). PubMed link DOI:10.3390/ijms18010024 |
| Barr IG and Wong FY | Avian influenza: why the concern? | 2016 | Microbiology Australia November. Website link DOI:10.1071/MA16055 |
| Lau H and Hurt AC | Assessment of the RNASound RNA sampling card for the preservation of influenza virus RNA | 2016 | Front Microbiol 7: 1736. PubMed link DOI:10.3389/fmicb.2016.01736 |
| Hurt AC, Su YC, Aban M, Peck H, Lau H, Baas C, Deng YM, Spirason N, Ellstrom P, Hernandez J, Olsen B, Barr IG, Vijaykrishna D and Gonzalez-Acuna D | Evidence for the introduction, reassortment, and persistence of diverse influenza A viruses in Antarctica | 2016 | J Virol 90(21): 9674-9682. PubMed link DOI:10.1128/JVI.01404-16 |
| Jelley L, Levy A, Deng YM, Spirason N, Lang J, Buettner I, Druce J, Blyth C, Effler P, Smith D and Barr IG | Influenza C infections in Western Australia and Victoria from 2008 to 2014 | 2016 | Influenza Other Respir Viruses 10(6): 455-461. PubMed link DOI:10.1111/irv.12402 |
| Moss R, McCaw JM, Cheng AC, Hurt AC and McVernon J | Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context | 2016 | BMC Infect Dis 16(1): 552. PubMed link DOI:10.1186/s12879-016-1866-7 |
| Komadina N, Quiñones-Parra SM, Kedzierska K, McCaw JM, Kelso A, Leder K and McVernon J | High conservation level of CD8+ T cell immunogenic regions within an unusual H1N2 human influenza variant | 2016 | J Med Virol 88(10): 1725-1732. PubMed link DOI:10.1002/jmv.24516 |
| Pennington K, Bareja C, Sullivan SG, Franklin LJ and Raupach J | Influenza surveillance in Australia | 2016 | Commun Dis Intell Q Rep 40(3): E315-E316. PubMed link |
| Sullivan SG, Raupach J, Franklin LJ, Pennington K, Bareja C, de Kluyver R and and the National Influenza Surveillance Committee | A brief overview of influenza surveillance systems in Australia, 2015 | 2016 | Commun Dis Intell Q Rep 40(3): E351-E355. PubMed link |
| Fielding JE, Levy A, Chilver MB, Deng YM, Regan AK, Grant KA, Stocks NP and Sullivan SG | Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment | 2016 | Vaccine 34(41): 4905-4912. PubMed link DOI:10.1016/j.vaccine.2016.08.067 |
| McBride WJ, Abhayaratna WP, Barr I, Booy R, Carapetis J, Carson S, De Looze F, Ellis-Pegler R, Heron L, Karrasch J, Marshall H, McVernon J, Nolan T, Rawlinson W, Reid J, Richmond P, Shakib S, Basser RL, Hartel GF, Lai MH, Rockman S and Greenberg ME | Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial | 2016 | Vaccine 34(41): 4991-4997. PubMed link DOI:10.1016/j.vaccine.2016.08.038 |
| Sullivan SG, Cowling BJ and Greenland S | Frailty and influenza vaccine effectiveness | 2016 | Vaccine 34(39): 4645-4646. PubMed link DOI:10.1016/j.vaccine.2016.08.003 |
| Gillespie L, Gerstenberg K, Ana-Sosa-Batiz F, Parsons MS, Farrukee R, Krabbe M, Spann K, Brooks AG, Londrigan SL and Reading PC | DC-SIGN and L-SIGN are attachment factors that promote infection of target cells by human metapneumovirus in the presence or absence of cellular glycosaminoglycans | 2016 | J Virol 90(17): 7848-7863. PubMed link DOI:10.1128/JVI.00537-16 |
| Sullivan SG, Tchetgen Tchetgen EJ and Cowling BJ | Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness | 2016 | Am J Epidemiol 184(5): 345-353. PubMed link DOI:10.1093/aje/kww064 |
| Sullivan SG, Carville KS, Chilver M, Fielding JE, Grant KA, Kelly H, Levy A, Stocks NP, Tempone SS and Regan AK | Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014 | 2016 | Epidemiol Infect 144(11): 2317-2328. PubMed link DOI:10.1017/S0950268816000819 |
| Gordon DL, Sajkov D, Honda-Okubo Y, Wilks SH, Aban M, Barr IG and Petrovsky N | Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax delta inulin adjuvant | 2016 | Vaccine 34(33): 3780-3786. PubMed link DOI:10.1016/j.vaccine.2016.05.071 |
| Job ER, Pizzolla A, Nebl T, Short KR, Deng YM, Carolan L, Laurie KL, Brooks AG and Reading PC | Neutralizing inhibitors in the airways of naive ferrets do not play a major role in modulating the virulence of H3 subtype influenza A viruses | 2016 | Virology 494: 143-157. PubMed link DOI:10.1016/j.virol.2016.01.024 |
| Milne GJ, Halder N, Kelso JK, Barr IG, Moyes J, Kahn K, Twine R and Cohen C | Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study | 2016 | Influenza Other Respir Viruses 10(4): 324-332. PubMed link DOI:10.1111/irv.12367 |
| Kristensen AB, Lay WN, Ana-Sosa-Batiz F, Vanderven HA, Madhavi V, Laurie KL, Carolan L, Wines BD, Hogarth M, Wheatley AK and Kent SJ | Antibody responses with Fc-mediated functions after vaccination of HIV-Infected subjects with trivalent influenza vaccine | 2016 | J Virol 90(12): 5724-5734. PubMed link DOI:10.1128/JVI.00285-16 |
| Hurt AC, Besselaar TG, Daniels RS, Ermetal B, Fry A, Gubareva L, Huang W, Lackenby A, Lee RT, Lo J, Maurer-Stroh S, Nguyen HT, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Tashiro M, Tilmanis D, Wang D, Zhang W and Meijer A | Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015 | 2016 | Antiviral Res 132: 178-185. PubMed link DOI:10.1016/j.antiviral.2016.06.001 |
| Bond HS, Sullivan SG, Cowling BJ | Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness | 2016 | Epidemiol Infect. 2016 Jun;144(8):1601-11 PubMed link doi: 10.1017/S095026881500309X |
| Dalziel AE, Peck HA, Hurt AC, Cooke J and Cassey P | Proposed surveillance for Influenza A in feral pigs | 2016 | Ecohealth 13(2): 410-414. PubMed link DOI:10.1007/s10393-016-1126-8 |
| Hurt AC and Kelly H | Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza | 2016 | Emerg Infect Dis 22(6): 949-955. PubMed link DOI:10.3201/eid2206.151037 |
| Vanderven HA, Ana-Sosa-Batiz F, Jegaskanda S, Rockman S, Laurie K, Barr I, Chen W, Wines B, Hogarth PM, Lambe T, Gilbert SC, Parsons MS and Kent SJ | What lies beneath: antibody dependent natural killer cell activation by antibodies to internal influenza virus proteins | 2016 | EBioMedicine 8: 277-290. PubMed link DOI:10.1016/j.ebiom.2016.04.029 |
| Li C, Hatta M, Burke DF, Ping J, Zhang Y, Ozawa M, Taft AS, Das SC, Hanson AP, Song J, Imai M, Wilker PR, Watanabe T, Watanabe S, Ito M, Iwatsuki-Horimoto K, Russell CA, James SL, Skepner E, Maher EA, Neumann G, Klimov AI, Kelso A, McCauley J, Wang D, Shu Y, Odagiri T, Tashiro M, Xu X, Wentworth DE, Katz JM, Cox NJ, Smith DJ and Kawaoka Y | Selection of antigenically advanced variants of seasonal influenza viruses | 2016 | Nat Microbiol 1(6): 16058. PubMed link DOI:10.1038/nmicrobiol.2016.58 |
| Ana-Sosa-Batiz F, Vanderven H, Jegaskanda S, Johnston A, Rockman S, Laurie K, Barr I, Reading P, Lichtfuss M and Kent SJ | Influenza-Specific Antibody-Dependent Phagocytosis | 2016 | PLoS One 11(4): e0154461. PubMed link DOI:10.1371/journal.pone.0154461 |
| Leung VK, Cowling BJ, Feng S and Sullivan SG | Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review | 2016 | Euro Surveill 21(16). PubMed link DOI:10.2807/1560-7917.ES.2016.21.16.30202 |
| Feng S, Cowling BJ and Sullivan SG | Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings | 2016 | Vaccine 34(14): 1672-1679. PubMed link DOI:10.1016/j.vaccine.2016.02.039 |
| FitzPatrick M, Royce SG, Langenbach S, McQualter J, Reading PC, Wijburg O, Anderson GP, Stewart A, Bourke J and Bozinovski S | Neonatal pneumococcal colonisation caused by influenza A infection alters lung function in adult mice | 2016 | Sci Rep 6: 22751. PubMed link DOI:10.1038/srep22751 |
| Carolan LA, Rockman S, Borg K, Guarnaccia T, Reading P, Mosse J, Kelso A, Barr I and Laurie KL | Characterization of the localized immune response in the respiratory tract of ferrets following infection with influenza A and B viruses | 2016 | J Virol 90(6): 2838-2848. PubMed link DOI:10.1128/JVI.02797-15 |
| Edenborough KM, Lowther S, Laurie K, Yamada M, Long F, Bingham J, Payne J, Harper J, Haining J, Arkinstall R, Gilbertson B, Middleton D and Brown LE | Predicting disease severity and viral spread of H5N1 influenza virus in ferrets in the context of natural exposure routes | 2016 | J Virol 90(4): 1888-1897. PubMed link DOI:10.1128/JVI.01878-15 |
| Oh DY and Hurt AC | Using the ferret as an animal model for investigating influenza antiviral effectiveness | 2016 | Front Microbiol 7: 80. PubMed link DOI:10.3389/fmicb.2016.00080 |
| Fielding JE, Regan AK, Dalton CB, Chilver MB and Sullivan SG | How severe was the 2015 influenza season in Australia? | 2016 | Med J Aust 204(2): 60-61. PubMed link |
| Kotecha RS, Wadia UD, Jacoby P, Ryan AL, Blyth CC, Keil AD, Gottardo NG, Cole CH, Barr IG and Richmond PC | Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer | 2016 | Cancer Med 5(2): 285-293. PubMed link DOI:10.1002/cam4.596 |
| Mifsud EJ, Tan AC, Reading PC and Jackson DC | Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam(2)Cys | 2016 | Immunol Cell Biol 94(2): 169-176. PubMed link DOI:10.1038/icb.2015.81 |
| Nguyen ML, Hatton L, Li J, Olshansky M, Kelso A, Russ BE and Turner SJ | Dynamic regulation of permissive histone modifications and GATA3 binding underpin acquisition of granzyme A expression by virus-specific CD8(+) T cells | 2016 | Eur J Immunol 46(2): 307-318. PubMed link DOI:10.1002/eji.201545875 |
| Ren B, McKinstry WJ, Pham T, Newman J, Layton DS, Bean AG, Chen Z, Laurie KL, Borg K, Barr IG and Adams TE | Structural and functional characterisation of ferret interleukin-2 | 2016 | Dev Comp Immunol 55: 32-38. PubMed link DOI:10.1016/j.dci.2015.10.007 |
| Barr IG, Vijaykrishna D and Sullivan SG | Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season | 2016 | Euro Surveill 21(4). PubMed link DOI:10.2807/1560-7917.ES.2016.21.4.30118 |
| Eichelberger MC, Couzens L, Gao Y, Levine M, Katz J, Wagner R, Thompson CI, Hoschler K, Laurie K, Bai T, Engelhardt OG and Wood J | Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity | 2016 | Vaccine 34(4): 458-465. PubMed link DOI:10.1016/j.vaccine.2015.12.022 |
| Gillespie L, Roosendahl P, Ng WC, Brooks AG, Reading PC and Londrigan SL | Endocytic function is critical for influenza A virus infection via DC-SIGN and L-SIGN | 2016 | Sci Rep 6: 19428. PubMed link DOI:10.1038/srep19428 |
| Tang FS, Van Ly D, Spann K, Reading PC, Burgess JK, Hartl D, Baines KJ and Oliver BG | Differential neutrophil activation in viral infections: Enhanced TLR-7/8-mediated CXCL8 release in asthma | 2016 | Respirology 21(1): 172-179. PubMed link DOI:10.1111/resp.12657 |
| Ng WC, Londrigan SL, Nasr N, Cunningham AL, Turville S, Brooks AG and Reading PC | The C-type lectin langerin functions as a receptor for attachment and infectious entry of influenza A virus | 2016 | J Virol 90(1): 206-221. PubMed link DOI:10.1128/JVI.01447-15 |